Vital Pharmaceuticals, Inc.
Vital Pharmaceuticals, Inc., commonly known for its flagship brand Bang Energy, is a leading player in the beverage industry, headquartered in the United States. Founded in 1993, the company has established itself as a pioneer in the performance energy drink sector, focusing on innovative formulations that cater to fitness enthusiasts and health-conscious consumers. With a strong presence across North America and expanding operations internationally, Vital Pharmaceuticals is renowned for its unique blend of energy-boosting ingredients and essential amino acids. The brand's commitment to quality and performance has garnered a loyal customer base, positioning it as a formidable competitor in the energy drink market. Notable achievements include rapid growth in market share and recognition for its cutting-edge product offerings, which continue to set trends within the industry.
DitchCarbon Score
How does Vital Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vital Pharmaceuticals, Inc.'s score of 28 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Vital Pharmaceuticals, Inc.'s reported carbon emissions
In 2023, Vital Pharmaceuticals, Inc. reported significant carbon emissions, totalling approximately 66,304,600 kg CO2e for Scope 1, 20,337,600 kg CO2e for Scope 2, and a substantial 27,348,482,000 kg CO2e for Scope 3 emissions. This data reflects a comprehensive approach to emissions reporting, covering all three scopes. Comparatively, in 2022, the company recorded Scope 1 emissions of about 45,210,600 kg CO2e, Scope 2 emissions of approximately 7,057,400 kg CO2e, and Scope 3 emissions of around 15,524,955,000 kg CO2e. This indicates a notable increase in emissions across all scopes, particularly in Scope 3, which is often the largest contributor in many industries. Vital Pharmaceuticals has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The absence of SBTi (Science Based Targets initiative) reduction targets suggests that the company may not yet have formalised its long-term climate strategy. The emissions data is not cascaded from any parent organisation, indicating that Vital Pharmaceuticals is independently reporting its carbon footprint. The company’s emissions intensity metrics, such as Scope 1 emissions intensity of about 9,140 kg CO2e per MBOE in 2023, provide further insight into its operational efficiency in relation to emissions. Overall, while Vital Pharmaceuticals has made strides in emissions reporting, the lack of reduction targets highlights an area for potential improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 1,070,077,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 20,288,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | 14,572,966,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vital Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
